Can medicine delivered with a click be trusted like the one handed by your local chemist? And therein lies the dilemma to which ePharmacies are now in. Even though the digital pharmacy has skyrocketed in the wake of the pandemic, the debate over its regulation, safety, and delivery trustworthiness refuses to die down.
The Allure of Speed, Undone by Gaps
The pitch was simple: Faster orders. Better prices. No queues.
But many found:
● Prescriptions were barely verified.
● Substitutes were sent without consent.
● Cold-chain drugs arrived warm.
● Timely delivery was often missed.
The speed promised is being undermined by systems not ready to scale. In many places, regulation arrived too late—or not at all. Laws written for brick-and-mortar setups don’t always fit the online world.
Where the Gaps Lie
● Prescription Mismanagement: Digital uploads are rarely verified by qualified pharmacists. In some cases, prescription-only drugs were shipped without checks. This poses risks of overuse, wrong dosage, or drug interactions.
● Unregulated Operators: Not all platforms are licensed. Aggregators list sellers with little oversight. Some operate across borders, evading local laws.
● Delivery Failures: Logistics partners often lack medical handling training. Medicines come late, in bad shape or wrongfully handled. Medications that are refrigerated such as insulin or vaccines are particularly susceptible.
● Patient Data at Risk: Privacy policies are vague. Browsing patterns, health conditions, and purchase history are often shared with advertisers. Consent is buried in fine print.
What Has Been Done (and What Has Not)
● In the EU, ePharmacies must display a common logo for authenticity.
● In the US, online pharmacies must be verified through the NABP.
● In the GCC, frameworks are evolving—Dubai has begun licensing but enforcement
varies.
But globally, few countries audit regularly or publish data on safety violations.ePharmacies
operating across borders are lost in the regulatory loop holes. Enforcement is still but
retrogressive, not preventive.
The Customer Pays the Price
Missed doses. Wrong meds. Cold-chain failures. The impact isn't just an inconvenience—it’s a
health risk. Especially for chronic patients, elderly users, or rural buyers who rely on timely
delivery.
Conclusion
ePharmacies have made access easier—but not safer. The promise is real, but the guardrails are
weak.
For this model to work, three things must happen:
● Regulations must catch up.
● Delivery chains must improve.
● Patients must stay informed.
Convenience should never come at the cost of care. And medicines should arrive right—not just
fast.